CHRS
Coherus BioSciences Inc
1.20$
+3.5%
vs. previous close
Closing price · As of: Sep 29, 2026
Statements
Cash Flow
Coherus BioSciences Inc (CHRS) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -120 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -54 | -13 | -47 | 60 | -62 | 29 | -26 | -47 | -46 | -20 | -58 | -120 | -244 | |
| 0.9 | 1.1 | 1.5 | 1.2 | 1.5 | 1.0 | 1.0 | 1.0 | 1.0 | 2.1 | 0.9 | 1.7 | 5.7 | |
| 10.0 | 11 | 7.3 | 7.2 | 6.9 | 6.4 | 5.4 | 5.4 | 3.4 | 11 | 2.4 | 5.0 | 22 | |
| -28 | 6.4 | -11 | 74 | -62 | 55 | 11 | -24 | -9.4 | -13 | -24 | -56 | -102 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| 51 | 35 | 203 | 28 | 0.4 | -0.5 | -17 | 463 | -67 | -2.8 | 31 | 60 | 21 | |
| -0.2 | 3.3 | -0.7 | -1.7 | 0.0 | 0.0 | -0.3 | – | 0.0 | -0.3 | – | – | – | |
| – | – | – | – | -0.1 | 0.0 | – | – | 0.0 | -48 | – | – | – | |
| 11 | 0.4 | 0.9 | -188 | -0.2 | 0.2 | -0.3 | -282 | 0.0 | 8.1 | 54 | 54 | 115 | |
| 7.4 | 22 | 157 | -101 | -62 | 28 | -44 | 134 | -114 | -14 | 26 | -6.0 | -108 | |
| -54 | -13 | -47 | 60 | -62 | 29 | -26 | -47 | -46 | -20 | -58 | -120 | -244 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.